UnitedHealth stock has so far disappointed investors in 2025, but the market could be surprised at its performance next year.
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFA26 Sept 2025, 15:45 UTC
AI-generated source summary
The video analyzes UnitedHealth stock (UNH). It uses a fundamental approach, citing the fiscal.ai platform for data, particularly forward price-to-earnings ratio (currently at 21.31). Estimates for the fiscal year 2027 earnings per share is at $20.81. Four scenarios are then analyzed. At its current P/E, the stock can potentially reach 443. 23 as the new P/E could increase up to 23 with the share potentially reaching 478 and a 25 P/E reaching $520 dollars, the baseline being at a $440-480 at the end of next year. A fail bound price is 333 due to some mistakes and underestimating cost for customers, that caused decrease in profitability, what is fixable by the management. As such, estimates point it towards a range between $440 and $480 by the end of the timeframe.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from Parkev Tatevosian, CFA
Coca-Cola Stock: Buy, Hold, or Sell? | KO Stock Analysis
SoFi Stock Analysis: Buy the Dip?
Should You Buy Micron Stock Instead of Nvidia Stock? | MU Stock vs. NVDA Stock
Should You Buy the Dip in Meta Stock? | META Stock Analysis and Live Earnings Review
Should Passive Income Investors Buy Colgate Palmolive Stock?
Procter & Gamble Stock: Buy, Hold, or Sell? | PG Stock Analysis
Parkev Tatevosian, CFA
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.